Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11877584 | 1.00 | TP53 (0.42) | TP53CYP3A4TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL19322469 | 1.00 | TP53 (0.42) | TP53CYP3A4TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL11877590 | 1.00 | TP53 (0.42) | TP53CYP3A4TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL630098 | 0.87 | MAPT (0.34) | TP53CYP3A4TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL11974570 | 0.87 | MAPT (0.34) | TP53CYP3A4TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL11876770 | 0.81 | MAPT (0.56) | TP53MAPK1SMN1; SMN2TDP1MAPT | |
| SCHEMBL2312130 | 0.81 | MAPT (0.56) | TP53MAPK1SMN1; SMN2TDP1MAPT | |
| SCHEMBL2389884 | 0.81 | ALDH1A1 (0.42) | SMN1; SMN2TDP1MAPTALDH1A1MEN1 | |
| SCHEMBL11973972 | 0.78 | MAPT (0.40) | MAPK1SMN1; SMN2TDP1MAPTALDH1A1 | |
| SCHEMBL630386 | 0.78 | MAPT (0.40) | MAPK1SMN1; SMN2TDP1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9759733-B1 | Mass produced, low cost, portable test kit for the detection and identification of narcotics | VERITEQUE USA, INC. | 2017-09-12 | — | — | US | claimed |
| WO-2010054441-A1 | NANOPIGMENTS | NVA IP HOLDINGS PTY LTD (AU) | 2010-05-20 | — | — | WO | claimed |
| US-20250297072-A1 | COLOR CHANGEABLE (METH)ACRYLATE COMPOSITIONS AND METHODS OF USING THE SAME | HENKEL AG & CO KGAA (DE) | 2025-09-25 | — | — | US | disclosed |
| US-20250108658-A1 | INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS | Prism Inks, Inc. (US) | 2025-04-03 | — | — | US | disclosed |
| US-12152172-B2 | One component (1K) anaerobic curable composition | HENKEL AG & CO. KGAA (DE) | 2024-11-26 | — | — | US | disclosed |
| EP-3660087-B1 | METHOD AND MATERIAL FOR THE PRODUCTION OF THREE-DIMENSIONAL OBJECTS BY ENERGY IMPULSE-INDUCED TRANSFER PRINTING | IVOCLAR VIVADENT AG (LI) | 2024-05-29 | — | — | EP | disclosed |
| US-20240010578-A1 | Smoke-Producing Compositions | ETIENNE LACROIX TOUS ARTIFICES S.A. (FR) | 2024-01-11 | — | — | US | disclosed |
| EP-4061864-B1 | ONE COMPONENT (1K) ANAEROBIC CURABLE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2023-10-18 | — | — | EP | disclosed |
| EP-4255870-A1 | SMOKE-PRODUCING COMPOSITIONS | Etienne Lacroix Tous Artifices S.A. (FR) | 2023-10-11 | — | — | EP | disclosed |
| CN-116867756-A | Fuming composition | 埃杰拉夸烟花股份有限公司 | 2023-10-10 | — | — | CN | disclosed |
| US-20230256651-A1 | SUPPORT MATERIAL FOR ENERGY-PULSE-INDUCED TRANSFER PRINTING | IO TECH GROUP LTD (GB) | 2023-08-17 | — | — | US | disclosed |
| US-20030068347-A1 | Use of microbially encapsulated meterials in cosmetic end formulations | CIBA SPECIALTY CHEMICALS CORP. | 2003-04-10 | — | — | US | disclosed |
| EP-1246602-A2 | USE OF MICROBIALLY ENCAPSULATED MATERIALS IN COSMETIC END FORMULATIONS | Ciba SC Holding AG (CH) | 2002-10-09 | — | — | EP | disclosed |
| EP-0744304-B1 | Tires with dyed indicia | GOODYEAR TIRE & RUBBER (US) | 2002-08-14 | — | — | EP | disclosed |
| US-20020106390-A1 | Use of nanodispersions in cosmetic end formulations | HUGLIN DIETMAR (DE) | 2002-08-08 | — | — | US | disclosed |
| WO-2001098757-A1 | VISUAL SPILL INDICATOR | IMBIBITIVE TECHNOLOGIES CORP. (US) | 2001-12-27 | — | — | WO | disclosed |
| WO-2001051013-A2 | USE OF MICROBIALLY ENCAPSULATED MATERIALS IN COSMETIC END FORMULATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-07-19 | — | — | WO | disclosed |
| US-6093271-A | COLORING OPAQUE NON-BLACK RUBBER(NBR) OF A PNEUMATIC TIRE BY MIXING NBR INCLUDING A COPOLYMER OF A C4-C7 MONOISOOLEFIN; APPLYING LIQUID PLASTICIZER-DYE MIXTURE TO RUBBER EXTERIOR WITHOUT ORGANIC SOLVENT; MAKING TIRE; MOLDING, CROSSLINKING | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2000-07-25 | — | — | US | disclosed |
| EP-0956851-A1 | Use of nanotopes in cosmetic products | Ciba SC Holding AG (CH) | 1999-11-17 | — | — | EP | disclosed |
| EP-0744304-A2 | Tires with dyed indicia | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1996-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030068347-A1 | Use of microbially encapsulated meterials in cosmetic end formulations | CUTA, MGLL, TMEM205 | TP53 1893/4885CYP3A4 3330/4885TSHR 3973/4885 |
| US-20020106390-A1 | Use of nanodispersions in cosmetic end formulations | NPC1L1, LIPA, CUTA | TP53 299/4885CYP3A4 2422/4885TSHR 3346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.